Antimetabolites: all 7,305 studies that test it
Page 53 of 74. Open to participants first (1,098), then studies with results posted, then the rest; newest registration first within each.
- IXO+A in mCRC With Liver-only MetastasesWithdrawnNCT01293942Phase 2
- Azacitidine in Treating Patients With Triple Negative Stage I-IV Invasive Breast Cancer That Can Be Removed By SurgeryWithdrawnNCT01292083Not applicable
- Phase I Study of Gemcitabine or S-1 Adjuvant Therapy After Hemihepatectomy for Biliary Tract CancerCompletedNCT01291615Phase 1
- A Phase I Study of S-1 in Combination With Radiotherapy in Locally Advanced or Recurrent Gastric CancerCompletedNCT01291407Phase 1
- Gemcitabine Plus Cisplatin Versus Gemcitabine Plus Paclitaxel in Triple Negative Breast Cancer (TNBC)CompletedNCT01287624Phase 3
- Neoadjuvant Combination Chemotherapy of DCS and DCF in Patients With Locally Advanced Gastric AdenocarcinomaCompletedNCT01286766Phase 2
- A Clinical Trial Using Metronomic Oral Low-dose Cyclophosphamide Alternating With Low-dose Oral Methotrexate With Continuous Celecoxib and Weekly Vinblastine in Children and Adolescents With Relapsed or Progressing soliD Tumours.CompletedNCT01285817Phase 2
- Gemcitabine/Cisplatin/S-1(GCS) Combination Therapy for Patients With Advanced Biliary Tract CancerCompletedNCT01284413Phase 1/2
- Trial of 4-regimen (SP, FL/Tax, FL/Doc, FOLFOX) in Patients With Recurrent or Metastatic Gastric CancerCompletedNCT01283204Phase 2
- Veliparib, Cisplatin, and Gemcitabine Hydrochloride in Treating Patients With Advanced Biliary, Pancreatic, Urothelial, or Non-Small Cell Lung CancerTerminatedNCT01282333Phase 1
- Safety of Clofarabine With Multiagent Chemotherapy in Childhood Acute Lymphoblastic LeukemiaCompletedNCT01279096Phase 1
- Dose Finding Study of Post-BMT Decitabine Maintenance Treatment in Higher-risk MDS and MDS/AMLStatus unknownNCT01277484Phase 1
- Tissue Pharmacokinetics of Intraoperative Gemcitabine in Resectable Adenocarcinoma of the PancreasTerminatedNCT01276613Early Phase 1
- Study of REOLYSIN® in Combination With FOLFIRI and Bevacizumab in FOLFIRI Naive Patients With KRAS Mutant Metastatic Colorectal CancerCompletedNCT01274624Phase 1
- Transanal Endoscopic Microsurgery (TEM) After Radiochemotherapy for Rectal CancerCompletedNCT01273051Phase 2
- Investigation of Association Between UGT1A1 Polymorphisms and Irinotecan Toxicity in Korean PatientsStatus unknownNCT01271582Phase 4
- Glivec® Plus m-FOLFOX Avastin® in Advanced Colorectal CancerTerminatedNCT01271166Phase 1
- A Trial of Induction Chemotherapy and Chemoradiotherapy With TS-1 and Cisplatin (SP) as First-line Treatment in Patients With High Risk Advanced Gastric CancerCompletedNCT01269255Phase 1
- A Study of Neoadjuvant Chemoradiotherapy With 5-FU/Leucovorin (FL) vs. TS-1/Irinotecan in Patients With Locally Advanced Rectal CancerCompletedNCT01269216Phase 2
- Neoadjuvant FDR GX in Locally Advanced Pancreatic CancerCompletedNCT01268384Phase 2
- A Randomized Study of GEMOX With or Without Cetuximab in Locally Advanced and Metastatic BTCCompletedNCT01267344Phase 2
- HLA-A*0201 Restricted Peptide Vaccine Therapy With Gemcitabine With Gemcitabine in Patient Pancreatic Cancer (Phase1)Status unknownNCT01266720Phase 1
- Oxaliplatin, Leucovorin, and Fluorouracil Before and After Radiation Therapy and Surgery in Treating Patients With Rectal Cancer That Can Be Removed by SurgeryCompletedNCT01263171Phase 2
- Evaluating Lapatinib + Capecitabine in Patients Aged 70 and Over With HER2 Metastatic Breast Cancer.CompletedNCT01262469Phase 2
- Azacitidine, Mitoxantrone Hydrochloride, and Etoposide in Treating Older Patients With Poor-Prognosis Acute Myeloid LeukemiaTerminatedNCT01260714Phase 1
- A Study of Perioperative Chemotherapy Plus Panitumumab in Patients With Colorectal Cancer Liver MetastasesCompletedNCT01260415Phase 2
- The Pharmacokinetics and Cardiac Properties of Elacytarabine (CP-4055)CompletedNCT01258816Phase 1
- Study of Tocilizumab in Combination With Methotrexate for Treatment of Moderate to Severe Rheumatoid Arthritis PatientsCompletedNCT01258712Phase 3
- Combination With Gemcitabine in Advanced Pancreatic CancerCompletedNCT01251640Phase 1/2
- Multicenter Study to Assess the Efficacy of Decitabine in the Treatment of Chronic Myelomonocytic LeukemiaCompletedNCT01251627Phase 2
- Cap+Bev vs Cap+Iri+Bev 1st-line Therapy in mCRCStatus unknownNCT01249638Phase 3
- Azacitidine in Combination With Mitoxantrone, Etoposide Phosphate, and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid LeukemiaCompletedNCT01249430Phase 1
- Umbilical Cord Blood Transplant for Children With Lymphoid Hematological MalignanciesWithdrawnNCT01247688Not applicable
- Intra-hepatic Chemotherapy in Patient With Non-resectable Liver Metastases From CholangiocarcinomaCompletedNCT01247337Phase 2
- Lenalidomide and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid LeukemiaCompletedNCT01246622Phase 1
- Induction Chemotherapy in Patients With Locoregionally Advanced Nasopharyngeal CarcinomaStatus unknownNCT01245959Phase 3
- Oxaliplatin and Capecitabine on Top of Sorafenib Versus Sorafenib Alone in Advanced Hepatocellular Carcinoma PatientsWithdrawnNCT01245582Phase 3
- ABC-04 a Study of Cisplatin, Gemcitabine and Selumetinib in Patients With Advanced Biliary Tract CancerCompletedNCT01242605Phase 1
- Methotrexate as a Steroid-sparing Agent in Idiopathic Retroperitoneal Fibrosis: a Randomised, Multicenter TrialStatus unknownNCT01240850Phase 3
- Panobinostat and Fluorouracil Followed By Leucovorin Calcium in Treating Patients With Stage IV Colorectal Cancer Who Did Not Respond to Previous Fluorouracil-Based ChemotherapyTerminatedNCT01238965Phase 1
- Study of NK012 and 5-FU/LV in Solid Tumors Followed by Dose Expansion in Colorectal CancerCompletedNCT01238939Phase 1
- Hematopoietic Stem Cell Transplantation for MucopolysaccharidosisStatus unknownNCT01238328Phase 2/3
- Dose Finding Study for Combination of Capecitabine, Lapatinib and Vinorelbine in Metastatic Breast CancerTerminatedNCT01238029Phase 1
- Azacitidine in Treating Patients With Chronic Myelomonocytic LeukemiaCompletedNCT01235117Phase 2
- Dasatinib and Gemcitabine Hydrochloride or Gemcitabine Hydrochloride Alone in Treating Patients With Pancreatic Cancer Previously Treated With SurgeryCompletedNCT01234935Phase 2
- ECX + Panitumumab vs. ECX Alone in Locally Advanced Gastric Cancer or Cancer of the Gastroesophageal JunctionCompletedNCT01234324Phase 2
- Chemoradiotherapy HNSCC, Randomized Study, Docetaxel,Cisplatin, 5FU,Erbitux.CompletedNCT01233843Phase 3
- Veliparib, Oxaliplatin, and Capecitabine in Treating Patients With Advanced Solid TumorsTerminatedNCT01233505Phase 1
- Study to Evaluate Efficacy of CO-1.01 as Second Line Therapy for Gemcitabine-Refractory Stage IV Pancreatic AdenocarcinomaCompletedNCT01233375Phase 2
- Study of Eniluracil + 5-Fluorouracil (5-FU) + Leucovorin Versus Capecitabine in Metastatic Breast CancerStatus unknownNCT01231802Phase 2
- Avastin and Chemotherapy Followed by a KRAS Stratified Randomization to Maintenance Treatment for First Line Treatment of Metastatic Colorectal Cancer.CompletedNCT01229813Phase 3
- Clofarabine or High-Dose Cytarabine and Pegaspargase in Children with ALLCompletedNCT01228331Phase 2/3
- Neoadjuvant Doxorubicin, Polyglutamate Paclitaxel, Capecitabine and Metronomic Chemotherapy in Breast CancerWithdrawnNCT01227408Phase 2
- Perioperative Vs. Preoperative Chemotherapy With Surgery in the Squamous Carcinoma of EsophagusCompletedNCT01225523Phase 1
- Cisplatin, Gemcitabine Hydrochloride, and Sorafenib Tosylate in Treating Patients With Transitional Cell Cancer of the BladderStatus unknownNCT01222676Phase 2
- 6xFU/Epirubicin/Cyclophosphamide (FEC) Compared to 3xFEC-3xDocetaxel in High-risk Node-negative Breast Cancer PatientsStatus unknownNCT01222052Phase 3
- 5-FU, Leucovorin, Oxaliplatin and Docetaxel (FLOT) Versus Epirubicin, Cisplatin and 5-FU (ECF) in Patients With Locally Advanced, Resectable Gastric CancerCompletedNCT01216644Phase 2/3
- Cetuximab + Gemox in Biliary Tract CancerCompletedNCT01216345Phase 2
- Hepatic Arterial Infusion Oxaliplatin, Capecitabine With or Without BevacizumabCompletedNCT01213238Phase 1
- Treated Blood Cells, Cyclophosphamide, Fludarabine Phosphate, and Aldesleukin in Treating Patients With CancerTerminatedNCT01212887Phase 1
- Study of Sapacitabine in Acute Myeloid Leukemia (AML) or Myelodysplastic Syndromes (MDS)Status unknownNCT01211457Phase 1/2
- Neoadjuvant FOLFOX6 Chemotherapy With or Without Radiation in Rectal CancerStatus unknownNCT01211210Phase 2/3
- Irinotecan Hydrochloride, Fluorouracil, and Leucovorin Calcium With or Without Zibotentan in Treating Patients With Metastatic Colorectal CancerCompletedNCT01205711Phase 2
- A Study of the Safety and Efficacy of CNTO 888 in Combination With SoC (Standard of Care) Chemotherapy in Patients With Solid TumorsCompletedNCT01204996Phase 1
- Adjuvant Chemotherapy for Elderly Non Frail Patients With an Increased Risk for Relapse of a Primary Carcinoma of the BreastCompletedNCT01204437Phase 2/3
- A Randomized Study to Determine the Efficacy of a Taxane and Bevacizumab With or Without Capecitabine as First Line Chemotherapy in Patients With Metastatic Breast CancerTerminatedNCT01200212Phase 3
- Gem-TABS in Unresectable Pancreatic CarcinomaCompletedNCT01198821Phase 1
- Vinorelbine and Gemcitabine Combination In Platinum Resistant Recurrent Ovarian CancerCompletedNCT01196559Phase 2
- Capecitabine and Mitomycin C in Treatment of Patients With Metastatic Breast CancerStatus unknownNCT01196455Phase 2
- Combination Chemotherapy Treatments in Patients With Colorectal Cancer Stage II and IIIStatus unknownNCT01196260Phase 2/3
- A Study of Clofarabine in Japanese Paediatric Patients With Relapsed or Refractory Acute Lymphoblastic LeukaemiaCompletedNCT01196013Phase 1
- S-1/Leucovorin (SL) Versus sLV5FU2 as the First-line Treatment for Elderly Patients With Colorectal CancerStatus unknownNCT01193452Phase 2
- Clofarabine and Low-dose Cytarabine Followed by Consolidation Therapy in AML Patients Age Greater Than or Equal to 60 YearsTerminatedNCT01193400Phase 2
- Study of Gefitinib Compared With Pemetrexed/Cisplatin in Advanced Non-Small Cell Lung Cancer PatientsStatus unknownNCT01192243Phase 2
- Safety and Tolerability Study of GSK1120212, a MEK Inhibitor, in Combination With Docetaxel, Erlotinib, Pemetrexed, Pemetrexed + Carboplatin, Pemetrexed + Cisplatin, or Nab-PaclitaxelCompletedNCT01192165Phase 1
- Busulfan (BU) Plus Fludarabine Vs Intravenous BU Plus Cyclophosphamide as Conditioning Regimens Prior Allogeneic Hematopoetic Stem Cells Transplant (HSCT) in AMLCompletedNCT01191957Phase 3
- A Study of Gemcitabine and Demcizumab (OMP-21M18) With or Without Abraxane® as 1st-line Treatment in Subjects With Locally Advanced or Metastatic Pancreatic CancerCompletedNCT01189929Phase 1
- Clofarabine/Ara-C Treatment Combined With Reduced-intensity Conditioning Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia in Primary Treatment FailureCompletedNCT01188174Phase 2
- Inflammatory Mediators in Obstructive Sleep Apnoea Syndrome; Mechanisms of Production and the Effect of Long Term Antioxidants AdministrationStatus unknownNCT01188005Not applicable
- Dose Ranging Study to Compare the Efficacy and Safety of Methotrexate in Plaque Type PsoriasisCompletedNCT01187264Phase 4
- Sorafenib Trial in Advanced and/or Recurrent Gastric Adenocarcinoma: Treatment Evaluation: STARGATECompletedNCT01187212Phase 2
- Combined Immunochemotherapy in Patients With T-Prolymphocytic Leukemia (T-PLL)CompletedNCT01186640Phase 2
- A Study of RO5083945 in Combination With Chemotherapy Versus Chemotherapy Alone in Patients With Advanced or Recurrent Non-Small Cell Lung CancerCompletedNCT01185847Phase 2
- Lenalidomide in Combination With Bevacizumab, Sorafenib, Temsirolimus, or 5-Fluorouracil, Leucovorin, Oxaliplatin (FOLFOX)CompletedNCT01183663Phase 1
- Study of Capecitabine in Metastatic Non-clear Cell Renal Cell Carcinoma (RCC) PatientsCompletedNCT01182142Phase 2
- Trial Evaluating Induction Therapy With Idarubicin and Etoposide Plus Sequential or Concurrent Azacitidine and Maintenance Therapy With AzacitidineCompletedNCT01180322Phase 2
- Pilot Study of Reduced-Intensity Hematopoietic Stem Cell Transplant of DOCK8 DeficiencyActive, not recruitingNCT01176006Phase 2
- Infusion of Off-the-Shelf Expanded Cord Blood Cells to Augment Cord Blood Transplant in Patients With Hematologic MalignanciesCompletedNCT01175785Phase 2
- Maintenance Treatment for Ovarian Carcinoma in Remission by an Antiangiogenic Treatment StrategyTerminatedNCT01175772Phase 2
- S-1 Plus Nedaplatin With Concurrent Radiotherapy for Advanced Esophageal CancerCompletedNCT01175460Phase 1
- S-1 and Radiotherapy in Elderly Patients With Esophageal CancerCompletedNCT01175447Phase 1
- Phase II Trial of Pemetrexed-Based Induction Chemotherapy Followed by Concomitant Chemoradiotherapy in Previously Irradiated Head and Neck Cancer PatientsCompletedNCT01172470Phase 2
- Pemetrexed Disodium and Docetaxel in Treating Patients With Advanced Solid TumorsCompletedNCT01172028Phase 1
- Leflunomide Versus Azathioprine for Maintenance Therapy of Lupus NephritisStatus unknownNCT01172002Not applicable
- Comparison Study of Sorafenib and 5-fluorouracil/Mitomycin for Metastatic Hepatocellular CarcinomaTerminatedNCT01171482Phase 2
- Ixabepilone and Pemetrexed/Solid TumorsWithdrawnNCT01170871Phase 1
- PK Study of Oral and IV Clofarabine in High Risk Myelodysplasia+Acute LeukemiasCompletedNCT01169012Phase 1
- Phase I Trial of 5-Azacitidine Plus Gemcitabine in Patients With Advanced Pancreatic CancerTerminatedNCT01167816Phase 1
- Xeloda Plus Paclitaxel in Gastric Cancer With Liver MetastasisStatus unknownNCT01167049Phase 2
- Safety of 24-hour Infusion of ON 01910.Na in Combination With Gemcitabine in Advanced Solid TumorsCompletedNCT01165905Phase 1